U.S. market Closed. Opens in 2 days 2 hours 59 minutes

LUCD | Lucid Diagnostics Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue2.43M377.00K500.00KN/AN/A
Cost of Revenue8.48M3.61M585.00KN/AN/A
Gross Profit-6.05M-3.24M-85.00KN/AN/A
Operating Expenses42.43M52.93M27.33M8.28M4.42M
Selling, General & Admin35.18M39.82M18.04M2.84M958.72K
Research & Development7.25M11.47M9.30M5.44M3.46M
Other Operating Expenses-4.17M1.65MN/AN/AN/A
Operating Income-48.48M-56.17M-27.42M-8.28M-4.42M
Other Expenses / Income-4.18MN/A-659.00K3.00-4.00
Before Tax Income-52.67M-56.17M-28.08M-8.28M-4.42M
Income Tax Expenses2.33M1.71M659.00K-8.28M-4.42M
Net Income-52.67M-56.17M-28.74M-8.28M-4.42M
Interest Expenses416.00K8.00K659.00KN/AN/A
Basic Shares Outstanding41.76M36.17M34.92M36.99M36.99M
Diluted Shares Outstanding41.76M36.17M34.92M36.99M36.99M
EBITDA-45.98M-54.23M-27.41M-8.28M-4.42M
EBITDA Margin-1,893.86%-14,385.94%-5,483.00%0.00%0.00%
EBIT-49.92M-54.46M-27.42M-16.56M-8.84M
EBIT Margin-2,055.97%-14,444.43%-5,483.80%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙